{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T12:08:06Z","timestamp":1794658086550,"version":"4.9.1"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T00:00:00Z","timestamp":1721779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T00:00:00Z","timestamp":1721779200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2018-02124"],"award-info":[{"award-number":["2018-02124"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2022-00799"],"award-info":[{"award-number":["2022-00799"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>\n                        <jats:bold>Abstract<\/jats:bold>\n                     <\/jats:title><jats:p>Maintenance of NAD pools is critical for neuronal survival. The capacity to maintain NAD pools declines in neurodegenerative disease. We identify that low NMNAT2, the critical neuronal NAD producing enzyme, drives retinal susceptibility to neurodegenerative insults. As proof of concept, gene therapy over-expressing full length human NMNAT2 is neuroprotective. To pharmacologically target NMNAT2, we identify that epigallocatechin gallate (EGCG) can drive NAD production in neurons through an NMNAT2 and NMN dependent mechanism. We confirm this by pharmacological and genetic inhibition of the NAD-salvage pathway. EGCG is neuroprotective in rodent (mixed sex) and human models of retinal neurodegeneration. As EGCG has poor drug-like qualities, we use it as a tool compound to generate novel small molecules which drive neuronal NAD production and provide neuroprotection. This class of NMNAT2 targeted small molecules could have an important therapeutic impact for neurodegenerative disease following further drug development.<\/jats:p>","DOI":"10.1038\/s41467-024-50354-5","type":"journal-article","created":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T16:01:55Z","timestamp":1721836915000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["NMNAT2 is a druggable target to drive neuronal NAD production"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8301-7358","authenticated-orcid":false,"given":"James R.","family":"Tribble","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8516-4706","authenticated-orcid":false,"given":"Melissa","family":"J\u00f6e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmine","family":"Varricchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amin","family":"Otmani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-9229-4710","authenticated-orcid":false,"given":"Alessio","family":"Canovai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9705-167X","authenticated-orcid":false,"given":"Baninia","family":"Habchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelia","family":"Daskalakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8042-1005","authenticated-orcid":false,"given":"Romanas","family":"Chaleckis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6535-6436","authenticated-orcid":false,"given":"Andrea","family":"Loreto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Gilley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8113-0653","authenticated-orcid":false,"given":"Craig E.","family":"Wheelock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gauti","family":"J\u00f3hannesson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8092-9455","authenticated-orcid":false,"given":"Raymond C. B.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9354-532X","authenticated-orcid":false,"given":"Michael P.","family":"Coleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9728-3419","authenticated-orcid":false,"given":"Andrea","family":"Brancale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6194-8397","authenticated-orcid":false,"given":"Pete A.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,24]]},"reference":[{"key":"50354_CR1","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1126\/science.aac4854","volume":"350","author":"E Verdin","year":"2015","unstructured":"Verdin, E. NAD+ in aging, metabolism, and neurodegeneration. Science 350, 1208\u20131213 (2015).","journal-title":"Science"},{"key":"50354_CR2","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1016\/j.ophtha.2014.05.013","volume":"121","author":"YC Tham","year":"2014","unstructured":"Tham, Y. C. et al. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology 121, 2081\u20132090 (2014).","journal-title":"Ophthalmology"},{"key":"50354_CR3","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1126\/science.aal0092","volume":"355","author":"PA Williams","year":"2017","unstructured":"Williams, P. A. et al. Vitamin B-3 modulates mitochondrial vulnerability and prevents glaucoma in aged mice. Science 355, 756\u2013760 (2017).","journal-title":"Science"},{"key":"50354_CR4","doi-asserted-by":"crossref","unstructured":"Harder, J. M. et al. Disturbed glucose and pyruvate metabolism in glaucoma with neuroprotection by pyruvate or rapamycin. Proc. Natl Acad. Sci. USA 117, 33619\u201333627 (2020).","DOI":"10.1073\/pnas.2014213117"},{"key":"50354_CR5","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcz035","volume":"1","author":"JR Tribble","year":"2019","unstructured":"Tribble, J. R. et al. Midget retinal ganglion cell dendritic and mitochondrial degeneration is an early feature of human glaucoma. Brain Commun. 1, fcz035 (2019).","journal-title":"Brain Commun."},{"key":"50354_CR6","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s40478-023-01513-0","volume":"11","author":"JR Tribble","year":"2023","unstructured":"Tribble, J. R. et al. NAD salvage pathway machinery expression in normal and glaucomatous retina and optic nerve. Acta Neuropathol. Commun. 11, 18 (2023).","journal-title":"Acta Neuropathol. Commun."},{"key":"50354_CR7","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.cmet.2019.09.001","volume":"30","author":"S Lautrup","year":"2019","unstructured":"Lautrup, S., Sinclair, D. A., Mattson, M. P. & Fang, E. F. NAD+ in brain aging and neurodegenerative disorders. Cell Metab. 30, 630\u2013655 (2019).","journal-title":"Cell Metab."},{"key":"50354_CR8","doi-asserted-by":"publisher","first-page":"e1356956","DOI":"10.1080\/19420889.2017.1356956","volume":"11","author":"PA Williams","year":"2018","unstructured":"Williams, P. A., Harder, J. M., Cardozo, B. H., Foxworth, N. E. & John, S. W. M. Nicotinamide treatment robustly protects from inherited mouse glaucoma. Commun. Integr. Biol. 11, e1356956 (2018).","journal-title":"Commun. Integr. Biol."},{"key":"50354_CR9","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1016\/j.ymthe.2022.01.035","volume":"30","author":"F Fang","year":"2022","unstructured":"Fang, F. et al. NMNAT2 is downregulated in glaucomatous RGCs, and RGC-specific gene therapy rescues neurodegeneration and visual function. Mol. Ther. 30, 1421\u20131431 (2022).","journal-title":"Mol. Ther."},{"key":"50354_CR10","doi-asserted-by":"publisher","first-page":"e1002472","DOI":"10.1371\/journal.pbio.1002472","volume":"14","author":"YO Ali","year":"2016","unstructured":"Ali, Y. O. et al. NMNAT2:HSP90 complex mediates proteostasis in proteinopathies. PLoS Biol. 14, e1002472 (2016).","journal-title":"PLoS Biol."},{"key":"50354_CR11","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1523\/JNEUROSCI.18-01-00138.1998","volume":"18","author":"RW Williams","year":"1998","unstructured":"Williams, R. W., Strom, R. C. & Goldowitz, D. Natural variation in neuron number in mice is linked to a major quantitative trait locus on Chr 11. J. Neurosci. 18, 138\u2013146 (1998).","journal-title":"J. Neurosci."},{"key":"50354_CR12","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1172\/JCI44646","volume":"121","author":"GR Howell","year":"2011","unstructured":"Howell, G. R. et al. Molecular clustering identifies complement and endothelin induction as early events in a mouse model of glaucoma. J. Clin. Investig. 121, 1429\u20131444 (2011).","journal-title":"J. Clin. Investig."},{"key":"50354_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2164-12-429","volume":"12","author":"GR Howell","year":"2011","unstructured":"Howell, G. R., Walton, D. O., King, B. L., Libby, R. T. & John, S. W. Datgan, a reusable software system for facile interrogation and visualization of complex transcription profiling data. BMC Genomics 12, 429 (2011).","journal-title":"BMC Genomics"},{"key":"50354_CR14","doi-asserted-by":"publisher","first-page":"13410","DOI":"10.1523\/JNEUROSCI.1534-13.2013","volume":"33","author":"J Gilley","year":"2013","unstructured":"Gilley, J., Adalbert, R., Yu, G. & Coleman, M. P. Rescue of peripheral and CNS axon defects in mice lacking NMNAT2. J. Neurosci. 33, 13410\u201313424 (2013).","journal-title":"J. Neurosci."},{"key":"50354_CR15","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1093\/hmg\/ddy356","volume":"28","author":"J Gilley","year":"2019","unstructured":"Gilley, J., Mayer, P. R., Yu, G. & Coleman, M. P. Low levels of NMNAT2 compromise axon development and survival. Hum. Mol. Genet 28, 448\u2013458 (2019).","journal-title":"Hum. Mol. Genet"},{"key":"50354_CR16","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1002\/cne.902510208","volume":"251","author":"P Carpenter","year":"1986","unstructured":"Carpenter, P., Sefton, A. J., Dreher, B. & Lim, W. L. Role of target tissue in regulating the development of retinal ganglion cells in the albino rat: effects of kainate lesions in the superior colliculus. J. Comp. Neurol. 251, 240\u2013259 (1986).","journal-title":"J. Comp. Neurol."},{"key":"50354_CR17","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/0014-4886(92)90164-L","volume":"116","author":"HE Pearson","year":"1992","unstructured":"Pearson, H. E. & Stoffler, D. J. Retinal ganglion cell degeneration following loss of postsynaptic target neurons in the dorsal lateral geniculate nucleus of the adult cat. Exp. Neurol. 116, 163\u2013171 (1992).","journal-title":"Exp. Neurol."},{"key":"50354_CR18","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1093\/hmg\/ddr492","volume":"21","author":"MC Ljungberg","year":"2012","unstructured":"Ljungberg, M. C. et al. CREB-activity and nmnat2 transcription are down-regulated prior to neurodegeneration, while NMNAT2 over-expression is neuroprotective, in a mouse model of human tauopathy. Hum. Mol. Genet 21, 251\u2013267 (2012).","journal-title":"Hum. Mol. Genet"},{"key":"50354_CR19","doi-asserted-by":"publisher","first-page":"36334","DOI":"10.1074\/jbc.M508660200","volume":"280","author":"F Berger","year":"2005","unstructured":"Berger, F., Lau, C., Dahlmann, M. & Ziegler, M. Subcellular compartmentation and differential catalytic properties of the three human nicotinamide mononucleotide adenylyltransferase isoforms. J. Biol. Chem. 280, 36334\u201336341 (2005).","journal-title":"J. Biol. Chem."},{"key":"50354_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2021.101988","volume":"43","author":"JR Tribble","year":"2021","unstructured":"Tribble, J. R. et al. Nicotinamide provides neuroprotection in glaucoma by protecting against mitochondrial and metabolic dysfunction. Redox Biol. 43, 101988 (2021).","journal-title":"Redox Biol."},{"key":"50354_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2019.104678","volume":"134","author":"A Loreto","year":"2020","unstructured":"Loreto, A. et al. Mitochondrial impairment activates the Wallerian pathway through depletion of NMNAT2 leading to SARM1-dependent axon degeneration. Neurobiol. Dis. 134, 104678 (2020).","journal-title":"Neurobiol. Dis."},{"key":"50354_CR22","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1207\/S15327914NC3701_5","volume":"37","author":"S Kim","year":"2000","unstructured":"Kim, S. et al. Plasma and tissue levels of tea catechins in rats and mice during chronic consumption of green tea polyphenols. Nutr. Cancer 37, 41\u201348 (2000).","journal-title":"Nutr. Cancer"},{"key":"50354_CR23","doi-asserted-by":"publisher","first-page":"133","DOI":"10.4161\/bioa.27049","volume":"3","author":"S Milde","year":"2013","unstructured":"Milde, S., Gilley, J. & Coleman, M. P. Axonal trafficking of NMNAT2 and its roles in axon growth and survival in vivo. Bioarchitecture 3, 133\u2013140 (2013).","journal-title":"Bioarchitecture"},{"key":"50354_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/srep02567","volume":"3","author":"S Milde","year":"2013","unstructured":"Milde, S., Fox, A. N., Freeman, M. R. & Coleman, M. P. Deletions within its subcellular targeting domain enhance the axon protective capacity of Nmnat2 in vivo. Sci. Rep. 3, 2567 (2013).","journal-title":"Sci. Rep."},{"key":"50354_CR25","doi-asserted-by":"publisher","first-page":"E8746","DOI":"10.1073\/pnas.1806933115","volume":"115","author":"DW Summers","year":"2018","unstructured":"Summers, D. W., Milbrandt, J. & DiAntonio, A. Palmitoylation enables MAPK-dependent proteostasis of axon survival factors. Proc. Natl Acad. Sci. USA 115, E8746\u2013E8754 (2018).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"50354_CR26","doi-asserted-by":"publisher","first-page":"e1001539","DOI":"10.1371\/journal.pbio.1001539","volume":"11","author":"S Milde","year":"2013","unstructured":"Milde, S., Gilley, J. & Coleman, M. P. Subcellular localization determines the stability and axon protective capacity of axon survival factor Nmnat2. PLoS Biol. 11, e1001539 (2013).","journal-title":"PLoS Biol."},{"key":"50354_CR27","doi-asserted-by":"publisher","first-page":"232","DOI":"10.3389\/fnins.2017.00232","volume":"11","author":"PA Williams","year":"2017","unstructured":"Williams, P. A. et al. Nicotinamide and WLDS act together to prevent neurodegeneration in glaucoma. Front. Neurosci. 11, 232 (2017).","journal-title":"Front. Neurosci."},{"key":"50354_CR28","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1083\/jcb.200706181","volume":"179","author":"GR Howell","year":"2007","unstructured":"Howell, G. R. et al. Axons of retinal ganglion cells are insulted in the optic nerve early in DBA\/2J glaucoma. J. Cell Biol. 179, 1523\u20131537 (2007).","journal-title":"J. Cell Biol."},{"key":"50354_CR29","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13024-021-00459-y","volume":"16","author":"ML Risner","year":"2021","unstructured":"Risner, M. L. et al. Neuroprotection by WldS depends on retinal ganglion cell type and age in glaucoma. Mol. Neurodegener. 16, 36 (2021).","journal-title":"Mol. Neurodegener."},{"key":"50354_CR30","doi-asserted-by":"publisher","first-page":"2871","DOI":"10.3390\/nu12092871","volume":"12","author":"G Cimaglia","year":"2020","unstructured":"Cimaglia, G., Votruba, M., Morgan, J. E., Andr\u00e9, H. & Williams, P. A. Potential therapeutic benefit of NAD+ supplementation for Glaucoma and Age-Related Macular Degeneration. Nutrients 12, 2871 (2020).","journal-title":"Nutrients"},{"key":"50354_CR31","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1111\/ceo.13818","volume":"48","author":"F Hui","year":"2020","unstructured":"Hui, F. et al. Improvement in inner retinal function in glaucoma with nicotinamide (vitamin B3) supplementation: a crossover randomized clinical trial. Clin. Exp. Ophthalmol. 48, 903\u2013914 (2020).","journal-title":"Clin. Exp. Ophthalmol."},{"key":"50354_CR32","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1001\/jamaophthalmol.2021.4576","volume":"140","author":"CG De Moraes","year":"2022","unstructured":"De Moraes, C. G. et al. Nicotinamide and pyruvate for neuroenhancement in open-angle glaucoma: A phase 2 randomized clinical trial. JAMA Ophthalmol. 140, 11\u201318 (2022).","journal-title":"JAMA Ophthalmol."},{"key":"50354_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12948","volume":"7","author":"SA Trammell","year":"2016","unstructured":"Trammell, S. A. et al. Nicotinamide riboside is uniquely and orally bioavailable in mice and humans. Nat. Commun. 7, 12948 (2016).","journal-title":"Nat. Commun."},{"key":"50354_CR34","doi-asserted-by":"publisher","first-page":"7097","DOI":"10.3390\/cimb45090449","volume":"45","author":"I Arizono","year":"2023","unstructured":"Arizono, I. et al. Axonal protection by oral nicotinamide riboside treatment with upregulated AMPK phosphorylation in a rat glaucomatous degeneration model. Curr. Issues Mol. Biol. 45, 7097\u20137109 (2023).","journal-title":"Curr. Issues Mol. Biol."},{"key":"50354_CR35","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/cdd.2014.164","volume":"22","author":"M Di Stefano","year":"2015","unstructured":"Di Stefano, M. et al. A rise in NAD precursor nicotinamide mononucleotide (NMN) after injury promotes axon degeneration. Cell Death Differ. 22, 731\u2013742 (2015).","journal-title":"Cell Death Differ."},{"key":"50354_CR36","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1126\/science.1258366","volume":"348","author":"J Gerdts","year":"2015","unstructured":"Gerdts, J., Brace, E. J., Sasaki, Y., DiAntonio, A. & Milbrandt, J. SARM1 activation triggers axon degeneration locally via NAD+ destruction. Science 348, 453\u2013457 (2015).","journal-title":"Science"},{"key":"50354_CR37","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1016\/j.neuron.2017.02.022","volume":"93","author":"K Essuman","year":"2017","unstructured":"Essuman, K. et al. The SARM1 toll\/interleukin-1 receptor domain possesses intrinsic NAD+ cleavage activity that promotes pathological axonal degeneration. Neuron 93, 1334\u20131343.e1335 (2017).","journal-title":"Neuron"},{"key":"50354_CR38","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2208457119","volume":"119","author":"HC Feldman","year":"2022","unstructured":"Feldman, H. C. et al. Selective inhibitors of SARM1 targeting an allosteric cysteine in the autoregulatory ARM domain. Proc. Natl Acad. Sci. USA 119, e2208457119 (2022).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"50354_CR39","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.exer.2018.03.007","volume":"171","author":"KA Fernandes","year":"2018","unstructured":"Fernandes, K. A. et al. Role of SARM1 and DR6 in retinal ganglion cell axonal and somal degeneration following axonal injury. Exp. Eye Res 171, 54\u201361 (2018).","journal-title":"Exp. Eye Res"},{"key":"50354_CR40","doi-asserted-by":"publisher","first-page":"e22540","DOI":"10.7554\/eLife.22540","volume":"6","author":"LJ Walker","year":"2017","unstructured":"Walker, L. J. et al. MAPK signaling promotes axonal degeneration by speeding the turnover of the axonal maintenance factor NMNAT2. Elife 6, e22540 (2017).","journal-title":"Elife"},{"key":"50354_CR41","doi-asserted-by":"publisher","first-page":"9329","DOI":"10.1128\/JVI.00836-09","volume":"83","author":"KJ Szretter","year":"2009","unstructured":"Szretter, K. J. et al. The immune adaptor molecule SARM modulates tumor necrosis factor alpha production and microglia activation in the brainstem and restricts West Nile Virus pathogenesis. J. Virol. 83, 9329\u20139338 (2009).","journal-title":"J. Virol."},{"key":"50354_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2022.860410","volume":"15","author":"CL Crawford","year":"2022","unstructured":"Crawford, C. L. et al. SARM1 depletion slows axon degeneration in a CNS model of neurotropic viral infection. Front Mol. Neurosci. 15, 860410 (2022).","journal-title":"Front Mol. Neurosci."},{"key":"50354_CR43","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1016\/j.bcp.2011.07.093","volume":"82","author":"BN Singh","year":"2011","unstructured":"Singh, B. N., Shankar, S. & Srivastava, R. K. Green tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms, perspectives and clinical applications. Biochem Pharm. 82, 1807\u20131821 (2011).","journal-title":"Biochem Pharm."},{"key":"50354_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.112372","volume":"42","author":"C Sun","year":"2023","unstructured":"Sun, C. et al. NAD depletion mediates cytotoxicity in human neurons with autophagy deficiency. Cell Rep. 42, 112372 (2023).","journal-title":"Cell Rep."},{"key":"50354_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2023.101193","volume":"92","author":"JR Tribble","year":"2023","unstructured":"Tribble, J. R. et al. Neuroprotection in glaucoma: mechanisms beyond intraocular pressure lowering. Mol. Asp. Med 92, 101193 (2023).","journal-title":"Mol. Asp. Med"},{"key":"50354_CR46","doi-asserted-by":"publisher","unstructured":"Sloan, Z. et al. GeneNetwork: framework for web-based genetics. J. Open Source Softw. 1 https:\/\/doi.org\/10.21105\/joss.00025 (2016).","DOI":"10.21105\/joss.00025"},{"key":"50354_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-25968-8","volume":"12","author":"P Gautam","year":"2021","unstructured":"Gautam, P. et al. Multi-species single-cell transcriptomic analysis of ocular compartment regulons. Nat. Commun. 12, 5675 (2021).","journal-title":"Nat. Commun."},{"key":"50354_CR48","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1016\/j.celrep.2019.12.082","volume":"30","author":"LD Orozco","year":"2020","unstructured":"Orozco, L. D. et al. Integration of eQTL and a single-cell atlas in the human eye identifies causal genes for age-related macular degeneration. Cell Rep. 30, 1246\u20131259.e1246 (2020).","journal-title":"Cell Rep."},{"key":"50354_CR49","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.exer.2015.09.012","volume":"143","author":"A Osborne","year":"2016","unstructured":"Osborne, A., Hopes, M., Wright, P., Broadway, D. C. & Sanderson, J. Human organotypic retinal cultures (HORCs) as a chronic experimental model for investigation of retinal ganglion cell degeneration. Exp. Eye Res. 143, 28\u201338 (2016).","journal-title":"Exp. Eye Res."},{"key":"50354_CR50","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1167\/tvst.10.1.21","volume":"10","author":"JR Tribble","year":"2021","unstructured":"Tribble, J. R. et al. Retinal ganglion cell degeneration in a rat magnetic bead model of ocular hypertensive glaucoma. Transl. Vis. Sci. Technol. 10, 21 (2021).","journal-title":"Transl. Vis. Sci. Technol."},{"key":"50354_CR51","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s40478-023-01642-6","volume":"11","author":"A Canovai","year":"2023","unstructured":"Canovai, A. et al. Pyrroloquinoline quinone drives ATP synthesis in vitro and in vivo and provides retinal ganglion cell neuroprotection. Acta Neuropathol. Commun. 11, 146 (2023).","journal-title":"Acta Neuropathol. Commun."},{"key":"50354_CR52","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/nmeth.3213","volume":"12","author":"J Yang","year":"2015","unstructured":"Yang, J. et al. The I-TASSER Suite: protein structure and function prediction. Nat. Methods 12, 7\u20138 (2015).","journal-title":"Nat. Methods"},{"key":"50354_CR53","doi-asserted-by":"publisher","first-page":"2440","DOI":"10.1002\/pro.526","volume":"19","author":"L Brunetti","year":"2010","unstructured":"Brunetti, L., Di Stefano, M., Ruggieri, S., Cimadamore, F. & Magni, G. Homology modeling and deletion mutants of human nicotinamide mononucleotide adenylyltransferase isozyme 2: new insights on structure and function relationship. Protein Sci. 19, 2440\u20132450 (2010).","journal-title":"Protein Sci."},{"key":"50354_CR54","doi-asserted-by":"publisher","first-page":"W423","DOI":"10.1093\/nar\/gkz403","volume":"47","author":"Y Karami","year":"2019","unstructured":"Karami, Y. et al. DaReUS-loop: a web server to model multiple loops in homology models. Nucleic Acids Res 47, W423\u2013W428 (2019).","journal-title":"Nucleic Acids Res"},{"key":"50354_CR55","doi-asserted-by":"publisher","first-page":"W407","DOI":"10.1093\/nar\/gkm290","volume":"35","author":"M Wiederstein","year":"2007","unstructured":"Wiederstein, M. & Sippl, M. J. ProSA-web: interactive web service for the recognition of errors in three-dimensional structures of proteins. Nucleic Acids Res 35, W407\u2013W410 (2007).","journal-title":"Nucleic Acids Res"}],"updated-by":[{"DOI":"10.1038\/s41467-024-52439-7","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,9,17]],"date-time":"2024-09-17T00:00:00Z","timestamp":1726531200000}}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-50354-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-50354-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-50354-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,21]],"date-time":"2024-09-21T10:01:31Z","timestamp":1726912891000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-50354-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,24]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["50354"],"URL":"https:\/\/doi.org\/10.1038\/s41467-024-50354-5","relation":{"correction":[{"id-type":"doi","id":"10.1038\/s41467-024-52439-7","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,24]]},"assertion":[{"value":"12 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2024","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41467-024-52439-7","URL":"https:\/\/doi.org\/10.1038\/s41467-024-52439-7","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"PAW is an inventor on an awarded US patent held by The Jackson Laboratory for nicotinamide treatment in glaucoma (\u201cTreatment and prevention of ocular neurodegenerative disorder\u201d, US11389439B2). PAW, MJ, CV, and AB are inventors on a submitted patent held by Mim Neurosciences AB for novel NMNAT2-targeting small molecules. All other authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6256"}}